SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Oric Pharmaceuticals, Inc. Common Stock

ORIC XNAS
$7.36 -0.33 (-4.29%) ▼ 15-min delayed
Open
$7.58
High
$8.00
Low
$7.28
Volume
1.46M
Market Cap
$764.94M

About Oric Pharmaceuticals, Inc. Common Stock

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 119 Website →

Related Market News

No specific coverage for ORIC yet. Check out our latest market news or earnings calendar.

Get ORIC Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Oric Pharmaceuticals, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.